Irkutsk
Ulan-Ude

Blagoveshchensk
Chita
Yakutsk

Birobidzhan
Vladivostok
Khabarovsk

Magadan
Yuzhno-Sakhalinsk

Anadyr
Petropavlovsk-
Kamchatsky
Moscow

This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.

Fraudsters started using COVID-19 medicine in schemes

Fraudsters started using COVID-19 medicine in schemes
Photo: pixabay.com
Fraud sites have appeared on the Internet that offer the drug favipiravir developed by the Russian Direct Investment Fund (RDIF). In addition to this, “private traders” joined in illegal actions.

According to the RDIF press service, the foundation’s specialists have already received signals about a number of announcements and fake Internet resources. On them, under the guise of drugs based on "Favipiravir" made in China and Japan, tablets without an active substance are sold. These drugs cannot be part of coronavirus therapy.

In this regard, the RDIF and KhimRar recall that the legal acquisition of Favipiravir in Russia is impossible. Moreover, this applies to both Japanese and Chinese products - there were no official deliveries of such drugs to the Russian market.

 ChemRar is the only manufacturer and supplier of the drug. It can also not be found in free sale - it is issued to patients only in medical institutions and under medical supervision. For the needs of Russian hospitals, the medicine will arrive on June 11.
September 28: current information on coronavirus in the Far East
Digest of regional events and latest statistics